Clinical Trials List
Protocol NumberMEK116513
2012-06-01 - 2014-06-30
Phase III
Terminated3
-
Trial Applicant
NOVARTIS (TAIWAN) CO., LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- Chia-Hsun Hsieh Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
- Wen-Pin Su Division of Hematology & Oncology
- Shang-Yin Wu Division of Hematology & Oncology
- Chia-Jui Yen Division of Hematology & Oncology
- 趙曉秋 Division of Dermatology
- Peng-Chan Lin Division of Hematology & Oncology
- Tak-Wah Wong Division of Dermatology
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
- HONG Jin-Bon 無
- 沈宜萱 無
- Ann-Lii Cheng 無
- Chih-Hung Hsu 無
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
5 participants
-
Global
694 participants
